Search Result "efficacy of polypharmacy"
Antipsychotic Polypharmacy
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 2231-2238
Author(s): J. Ananth, S. Parameswaran, Gunatilake
Polypharmacy in Psychiatry: An In-depth Examination of Drug-drugInteractions and Treatment Challenges
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 21 Year: 2024 Page: 1641-1649
Author(s):
Antipsychotic Polypharmacy in Elderly Patients
Ebook: Psychopharmacological Issues in Geriatrics
Volume: 1 Year: 2015
Author(s): Amaia Lopez de Torre
Doi: 10.2174/9781681080345115010016
Antipsychotic Polypharmacy: Still Dirty, But Hardly a Secret. A Systematic Review and Clinical Guide
Journal: Current Psychopharmacology
Volume: 2 Issue: 2 Year: 2013 Page: 143-171
Author(s): Derek K. Tracy,Kyra-Verena Sendt,Sukhwinder S. Shergill
A Critical Review of Atypical Antipsychotic Utilization: Comparing Monotherapy with Polypharmacy and Augmentation
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2004 Page: 313-327
Author(s): S. M Stahl, M. M. Grady
Increase in Antipsychotic Polypharmacy Treatment in Patients with Schizophrenia Between 1994-2000 and 2010
Journal: Current Psychopharmacology
Volume: 3 Issue: 2 Year: 2014 Page: 108-112
Author(s): Deniz Ceylan,Ahmet Aktener,Berna B. Akdede,Koksal Alptekin
Antipsychotic Polypharmacy in Schizophrenia, from Empirical Associations to Combined Selective Treatments
Ebook: Frontiers in CNS Drug Discovery
Volume: 2 Year: 2013
Author(s): Alessandro De Risio,Davide Carlino
Doi: 10.2174/9781608057672113020008
Antiepileptic Drugs (AEDs) Polypharmacy Could Lead to Buried Pharmacokinetic Interactions due to CYP450
Journal: Drug Metabolism Letters
Volume: 6 Issue: 3 Year: 2012 Page: 207-212
Author(s): Z. Tolou-Ghamari
Lignans' Potential in Pre and Post-onset Type 2 Diabetes Management
Journal: Current Diabetes Reviews
Volume: 16 Issue: 1 Year: 2020 Page: 2-11
Author(s): Douglas Edward Barre,Kazimiera Amella Mizier-Barre
Impact of Polypharmacy on Adherence to Evidence-Based Medication in Patients who Underwent Percutaneous Coronary Intervention
Journal: Current Vascular Pharmacology
Volume: 14 Issue: 4 Year: 2016 Page: 388-393
Author(s): Shaban Mohammed, Abdulrahaman Arabi, Ayman El-Menyar, Sabir Abdulkarim, Amer AlJundi, Awad Alqahtani, Salah Arafa, Jassim Al Suwaidi